Your browser doesn't support javascript.
Posterior reversible encephalopathy syndrome (PRES): Another imaging manifestation of COVID-19.
Rogg, Jeffrey; Baker, Amanda; Tung, Glenn.
  • Rogg J; Department of Diagnostic Imaging, Rhode Island Hospital, Alpert Medical School of Brown University, United States.
  • Baker A; Department of Diagnostic Imaging, Rhode Island Hospital, Alpert Medical School of Brown University, United States.
  • Tung G; Department of Diagnostic Imaging, Rhode Island Hospital, Alpert Medical School of Brown University, United States.
Interdiscip Neurosurg ; 22: 100808, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-643652
ABSTRACT
Neuroimaging manifestations of COVID-19 are being reported with increasing frequency with recent reports of associated atypical leukoencephalopathies. We add to this literature by describing a COVID-19 + patient who demonstrated imaging findings typical for posterior reversible encephalopathy syndrome (PRES). The inflammatory syndrome associated with novel corona virus infection has shown markedly increased levels of cytokines and inflammatory markers. This has also been described in a proposed mechanism for PRES, where elevated inflammatory markers result in endothelial injury causing interstitial fluid extravasation typical of PRES. We expect that other cases of PRES will be observed in this population given the scope of the Covid-19 pandemic.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Interdiscip Neurosurg Year: 2020 Document Type: Article Affiliation country: J.inat.2020.100808

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Language: English Journal: Interdiscip Neurosurg Year: 2020 Document Type: Article Affiliation country: J.inat.2020.100808